by HealthDay Reporter | Apr 22, 2024
Intrathecal gene transfer with scAAV9/JeT-GAN may show some benefit in motor function for children with giant axonal neuropathy. Intrathecal gene transfer with scAAV9/JeT-GAN may result in some benefit for children with giant axonal neuropathy, according...
by HealthDay Reporter | Apr 18, 2024
Acute respiratory failure and sepsis were the most common reasons for ICU admission. For hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a...
by HealthDay Reporter | Apr 16, 2024
Dramatic and rapid radiographic tumor regression seen in three cases of recurrent glioblastoma; transient responses seen in two patients. For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to...
by HealthDay Reporter | Apr 15, 2024
Most reports of SPMs included axicabtagene ciloleucel and tisagenlecleucel; most frequent SPMs were leukemias. Second primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen...
by HealthDay Reporter | Apr 11, 2024
Rates of receipt of recommended antibiotic prophylaxis and annual transcranial Doppler low. A number of children with sickle cell anemia (SCA) have low rates of receipt of recommended antibiotic prophylaxis and annual transcranial Doppler (TCD)...
